Literature DB >> 19812918

Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain.

Tomoya Nakamachi1, Hirokazu Ohtaki, Sachiko Yofu, Kenji Dohi, Jun Watanabe, Hiroyoshi Mori, Atsushi Sato, Hitoshi Hashimoto, Norihito Shintani, Akemichi Baba, Seiji Shioda.   

Abstract

Pituitary adenylate cyclase activating polypeptide is a pleiotropic neuropeptide. We previously showed that heterozygous PACAP gene knockout (PACAP(+/-)) mice had larger infarct volumes and worse neurological scores after middle cerebral artery occlusion (MCAO). However, the relationship between endogenous PACAP levels and edema in the ischemic brain has not yet been evaluated. In this study, the formation of edema in the ischemic brain as well as cerebral blood flow was compared between PACAP(+/-) and wild-type (PACAP(+/+)) mice. The amount of brain edema was calculated by subtracting the contralateral volume from the ipsilateral volume 24 h after permanent MCAO. PACAP(+/-) mice showed significantly greater brain edema than PACAP(+/+) mice. To investigate the effects of endogenous PACAP on blood flow during ischemia, cerebral blood flow in the ipsilateral and the contralateral cortices was compared between PACAP(+/-) and PACAP(+/+) mice for 25 min after ischemia. With a two-dimensional laser Doppler perfusion imaging system, the blood flow in the ipsilateral and contralateral cortices was shown to be similar in PACAP(+/-) and PACAP(+/+) mice during ischemia. These results suggest that endogenous PACAP suppresses the formation of edema in the ischemic brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19812918     DOI: 10.1007/978-3-211-98811-4_6

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  24 in total

1.  IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Masashi Tsuchida; Nobuyuki Kagami; Sachiko Yofu; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Akira Yoshikawa; Nori Imai; Keisuke Nakamura; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Zsuzsanna Marton; Monika Griecs; Levente Hamza; Valeria Gaal; Zsolt Biro; Andrea Tamas; Gabor Hild; Miklos Nyitrai; Gabor Toth; Dora Reglodi; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2010-06-03       Impact factor: 3.444

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation of reactive astrocytes in vitro.

Authors:  Tomoya Nakamachi; Keisuke Nakamura; Kanako Oshida; Nobuyuki Kagami; Hiroyoshi Mori; Jun Watanabe; Satoru Arata; Sachiko Yofu; Kimi Endo; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Makoto Kato; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2010-06-24       Impact factor: 3.444

4.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

5.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.

Authors:  K Szabadfi; T Atlasz; P Kiss; B Danyadi; A Tamas; Zs Helyes; H Hashimoto; N Shintani; A Baba; G Toth; R Gabriel; D Reglodi
Journal:  Neurotox Res       Date:  2011-06-30       Impact factor: 3.911

6.  Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.

Authors:  A Nemeth; K Szabadfi; B Fulop; D Reglodi; P Kiss; J Farkas; B Szalontai; R Gabriel; H Hashimoto; A Tamas
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 7.  VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.

Authors:  Terry W Moody; Tetsuhide Ito; Nuramy Osefo; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

8.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Authors:  Jozsef Farkas; Balazs Sandor; Andrea Tamas; Peter Kiss; Hitoshi Hashimoto; Andras D Nagy; Balazs D Fulop; Tamas Juhasz; Sridharan Manavalan; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2017-02-06       Impact factor: 3.444

9.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

10.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.